AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15148924 — intervention group
Group type: COMPARATOR
Intervention: Control Group (not explicitly mentioned)
Number of subjects: 72
Study 12171964 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (12 billion colony forming units)
Number of subjects: 37
Study 12171964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 12171964 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 37
Study 12171964 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG and Placebo
Number of subjects: 37
Study 9614307 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal
Number of subjects: 6
Study 9614307 — intervention group
Group type: COMPARATOR
Intervention: Solid meal
Number of subjects: 6
Study 9614307 — intervention group
Group type: COMPARATOR
Intervention: Soups with differing fat saturation
Number of subjects: 6
Study 9536926 — intervention group
Group type: EXPERIMENTAL
Intervention: NG‐monomethyl L‐arginine (3 mg h‐1 kg‐1)
Number of subjects: 16
Study 9536926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 1990984 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic topical steroids
Number of subjects: 6
Study 1990984 — intervention group
Group type: COMPARATOR
Intervention: Trade-name topical steroids
Number of subjects: 6
Study 6337004 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol (PGI2) infusion at doses of 2, 4, 6, and 8 ng/kg/min
Number of subjects: 0
Study 6337004 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole (400 mg/day for 3 days)
Number of subjects: 0
Study 31926328 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive treatment (endoscopic approach)
Number of subjects: 145
Study 31926328 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bascom cleft lift treatment
Number of subjects: 145
Study 31926328 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis of minimally invasive treatment
Number of subjects: 145
Study 30474448 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated proton therapy (IMPT)
Number of subjects: 25
Study 30474448 — intervention group
Group type: COMPARATOR
Intervention: Tomotherapy (TOMO)
Number of subjects: 25
Study 30474448 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 25
Study 30739899 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbershop Talk with Brothers (BTWB) project
Number of subjects: 860
Study 27117045 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 51
Study 27117045 — intervention group
Group type: COMPARATOR
Intervention: Minimal effort walking
Number of subjects: 51
Study 24190860 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose n-3 PUFA (Lovaza 3600 mg/day)
Number of subjects: 60
Study 24190860 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose n-3 PUFA (Lovaza 900 mg/day)
Number of subjects: 60
Study 24190860 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22569895 — intervention group
Group type: EXPERIMENTAL
Intervention: VD(3) encapsulated in rCM, 50,000 IU, in 1% fat milk
Number of subjects: 87
Study 22569895 — intervention group
Group type: COMPARATOR
Intervention: Tween‐80 emulsified VD(3)
Number of subjects: 87
Study 22569895 — intervention group
Group type: COMPARATOR
Intervention: Unencapsulated VD(3)
Number of subjects: 87
Study 22569895 — intervention group
Group type: EXPERIMENTAL
Intervention: VD(3) encapsulated in rCM after ultra-high-pressure homogenization
Number of subjects: 87
Study 20483364 — intervention group
Group type: COMPARATOR
Intervention: NoGo-switch (Go/NoGo)
Number of subjects: 24
Study 20483364 — intervention group
Group type: COMPARATOR
Intervention: NoGo-repeat (NoGo/NoGo)
Number of subjects: 24
Study 20483364 — intervention group
Group type: EXPERIMENTAL
Intervention: NoGo-N200
Number of subjects: 24
Study 20483364 — intervention group
Group type: EXPERIMENTAL
Intervention: Go-trials
Number of subjects: 24
Study 17337426 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate 100 mg oral treatment
Number of subjects: 150
Study 17337426 — intervention group
Group type: COMPARATOR
Intervention: Control group (non diabetic males)
Number of subjects: 150
Study 17337426 — intervention group
Group type: COMPARATOR
Intervention: Non neuropathic diabetic patients
Number of subjects: 150
Study 15778966 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dose hepatitis B vaccination course (Engerix B GlaxoSmithKline) administered at 0, 1, and 12 months; adult dose containing 20 mug recombinant hepatitis B surface antigen in 1 ml suspension.
Number of subjects: 528
Study 12224782 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsmokers exposed to cigarette smoke
Number of subjects: 848
Study 12224782 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers not exposed to smoke
Number of subjects: 848
Study 12224782 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive smoking
Number of subjects: 848
Study 9295239 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid daily for six months
Number of subjects: 2736
Study 9295239 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid and rifampin daily for three months
Number of subjects: 2736
Study 9295239 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid, rifampin, and pyrazinamide daily for three months
Number of subjects: 2736
Study 9295239 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid for six months
Number of subjects: 2736
Study 9295239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2736
Study 7509573 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured sensorimotor therapy
Number of subjects: 12
Study 7509573 — intervention group
Group type: COMPARATOR
Intervention: Child-centered therapy
Number of subjects: 12
Study 7509573 — intervention group
Group type: COMPARATOR
Intervention: Both therapies
Number of subjects: 12
Study 3539030 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms intranasal DDAVP
Number of subjects: 17
Study 3539030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 3539030 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms DDAVP during school journeys or holidays
Number of subjects: 17
Study 30358181 — intervention group
Group type: EXPERIMENTAL
Intervention: Speeded intervention (n=211)
Number of subjects: 639
Study 30358181 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspeeded intervention (n=204)
Number of subjects: 639
Study 30358181 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=224)
Number of subjects: 639
Study 29680359 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 meals/day
Number of subjects: 47
Study 29680359 — intervention group
Group type: COMPARATOR
Intervention: 3 meals/day
Number of subjects: 47
Study 27333895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warnings
Number of subjects: 1413
Study 27333895 — intervention group
Group type: COMPARATOR
Intervention: Text warnings
Number of subjects: 1413
Study 27333895 — intervention group
Group type: EXPERIMENTAL
Intervention: Reactance factors (anger, exaggeration, government, manipulation, personal attack)
Number of subjects: 1413
Study 23531574 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health care management program (OHMP) focusing on self-efficacy and self-management
Number of subjects: 0
Study 23531574 — intervention group
Group type: COMPARATOR
Intervention: Control group 1
Number of subjects: 0
Study 23531574 — intervention group
Group type: COMPARATOR
Intervention: Control group 2
Number of subjects: 0
Study 22236849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention centres with child TB guidelines, training, and logistics support
Number of subjects: 36
Study 22236849 — intervention group
Group type: COMPARATOR
Intervention: Control centres with usual practice
Number of subjects: 36
Study 20236776 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal oestradiol (25 micrograms, Vagifem, Novo Nordisk) once daily for 2 weeks, then twice weekly for 6 months (group 1)
Number of subjects: 190
Study 20236776 — intervention group
Group type: COMPARATOR
Intervention: TVT-O procedure only (group 2)
Number of subjects: 190
Study 18768943 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 2521
Study 18768943 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 2521
Study 18768943 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 2521
Study 15866552 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone alone
Number of subjects: 254
Study 15866552 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram and naltrexone (open-label disulfiram and blinded naltrexone)
Number of subjects: 254
Study 15866552 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram and placebo (open-label disulfiram and blinded placebo)
Number of subjects: 254
Study 15866552 — intervention group
Group type: COMPARATOR
Intervention: Placebo alone
Number of subjects: 254
Study 12872170 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90
Study 12872170 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental and isoflurane
Number of subjects: 90
Study 12872170 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental, nitrous oxide, and low-dose isoflurane
Number of subjects: 90
Study 10537257 — intervention group
Group type: EXPERIMENTAL
Intervention: UHR system (Osteonics)
Number of subjects: 0
Study 10537257 — intervention group
Group type: EXPERIMENTAL
Intervention: All bipolar prostheses
Number of subjects: 0
Study 10537257 — intervention group
Group type: EXPERIMENTAL
Intervention: Some prostheses
Number of subjects: 0
Study 10537257 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar endoprostheses
Number of subjects: 0
Study 8927680 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotepine (150 to 300 mg)
Number of subjects: 126
Study 8927680 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (10 to 20 mg)
Number of subjects: 126
Study 1294919 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl 70-80 micrograms/hr
Number of subjects: 21
Study 1294919 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal fentanyl 90-100 micrograms/hr
Number of subjects: 21
Study 1294919 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine 150 micrograms/kg every 6h
Number of subjects: 21
Study 6364994 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% sulconazole cream
Number of subjects: 192
Study 6364994 — intervention group
Group type: COMPARATOR
Intervention: 2% miconazole cream
Number of subjects: 192
Study 31140355 — intervention group
Group type: EXPERIMENTAL
Intervention: IVT + EVT
Number of subjects: 1485
Study 31140355 — intervention group
Group type: COMPARATOR
Intervention: EVT alone
Number of subjects: 1485
Study 26663743 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese victim and nonobese perpetrator scenario
Number of subjects: 0
Study 26663743 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese perpetrator and nonobese victim scenario
Number of subjects: 0
Study 26663743 — intervention group
Group type: EXPERIMENTAL
Intervention: Both victim and perpetrator described as obese
Number of subjects: 0
Study 26663743 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese victim scenario
Number of subjects: 0
Study 26663743 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese perpetrator scenario
Number of subjects: 0
Study 26891677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower MAP target (60-65 mmHg)
Number of subjects: 118
Study 26891677 — intervention group
Group type: COMPARATOR
Intervention: Higher MAP target (75-80 mmHg)
Number of subjects: 118
Study 26891677 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower MAP target (60-65 mmHg) among patients aged 75 years or older
Number of subjects: 118
Study 26891677 — intervention group
Group type: COMPARATOR
Intervention: Higher MAP target (75-80 mmHg) among patients aged 75 years or older
Number of subjects: 118
Study 24901490 — intervention group
Group type: EXPERIMENTAL
Intervention: Limbal‐conjunctival autograft with mitomycin C (MMC+)
Number of subjects: 68
Study 24901490 — intervention group
Group type: COMPARATOR
Intervention: Limbal‐conjunctival autograft without mitomycin C (MMC-)
Number of subjects: 68
Study 24901490 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MMC+ and MMC-)
Number of subjects: 68
Study 24901490 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative corneal astigmatism (PRCA)
Number of subjects: 68
Study 24901490 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold for astigmatism reduction
Number of subjects: 68
Study 22480758 — intervention group
Group type: COMPARATOR
Intervention: 8×B(esc) group
Number of subjects: 2182
Study 22480758 — intervention group
Group type: EXPERIMENTAL
Intervention: 6×B(esc) group
Number of subjects: 2182
Study 22480758 — intervention group
Group type: EXPERIMENTAL
Intervention: 8×B(14) group
Number of subjects: 2182
Study 22480758 — intervention group
Group type: EXPERIMENTAL
Intervention: PET-guided radiotherapy
Number of subjects: 2182
Study 19944580 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4mg
Number of subjects: 0
Study 19944580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 0.005 mg/kg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 0.01 mg/kg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 0.02 mg/kg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 0.5 mg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 0.75 mg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide 1.0 mg
Number of subjects: 40
Study 18035195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibutilide (all doses)
Number of subjects: 40
Study 16223390 — intervention group
Group type: EXPERIMENTAL
Intervention: J‐wire tip directed downward
Number of subjects: 140
Study 16223390 — intervention group
Group type: COMPARATOR
Intervention: J‐wire tip directed upward
Number of subjects: 140
Study 12042266 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilostane
Number of subjects: 116
Study 12042266 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 12042266 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilostane 1080 mg
Number of subjects: 116
Study 12042266 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilostane 720 mg
Number of subjects: 116
Study 12042266 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilostane + Danazol
Number of subjects: 116
Study 10214664 — intervention group
Group type: EXPERIMENTAL
Intervention: New corticosteroid drug
Number of subjects: 69
Study 10214664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 7833731 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpropamide
Number of subjects: 2520
Study 7833731 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 2520
Study 7833731 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 2520
Study 7833731 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (in obese subjects)
Number of subjects: 2520
Study 7833731 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 2520
Study 2226910 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethindrone 1 mg/mestranol 0.05 mg/d (group A)
Number of subjects: 48
Study 2226910 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group B)
Number of subjects: 48
Study 999082 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 366
Study 999082 — intervention group
Group type: COMPARATOR
Intervention: Spinal or general anesthesia
Number of subjects: 366
Study 31159548 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy with automated instillation
Number of subjects: 41
Study 31159548 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard negative pressure therapy)
Number of subjects: 41
Study 27513627 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad administration of ICIQ questionnaires
Number of subjects: 448
Study 27513627 — intervention group
Group type: COMPARATOR
Intervention: Telephone administration of ICIQ questionnaires
Number of subjects: 448
Study 27513627 — intervention group
Group type: COMPARATOR
Intervention: Paper administration of ICIQ questionnaires
Number of subjects: 448
Study 25533601 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise program (3 sets of 10 to 12 leg extensions at 70% of estimated 1-repetition maximum thrice weekly for 8 weeks)
Number of subjects: 38
Study 25533601 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control (usual physical activity)
Number of subjects: 38
Study 23604170 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcone disc stimulation
Number of subjects: 12
Study 23604170 — intervention group
Group type: COMPARATOR
Intervention: Flat disc stimulation
Number of subjects: 12
Study 20078697 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step self-etch bonding agent
Number of subjects: 40
Study 20078697 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step total-etch bonding agent
Number of subjects: 40
Study 20078697 — intervention group
Group type: COMPARATOR
Intervention: Unetched-cavity control group
Number of subjects: 40
Study 20078697 — intervention group
Group type: COMPARATOR
Intervention: Intact-teeth control group
Number of subjects: 40
Study 18328039 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacemaker in patients with no AF history (G1)
Number of subjects: 410
Study 18328039 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacemaker in patients with history of paroxysmal/persistent AF (G2)
Number of subjects: 410
Study 18328039 — intervention group
Group type: COMPARATOR
Intervention: Before AF onset
Number of subjects: 410
Study 18328039 — intervention group
Group type: COMPARATOR
Intervention: During persistent AF
Number of subjects: 410
Study 15672116 — intervention group
Group type: EXPERIMENTAL
Intervention: High calcium and normal protein (HC/NP: 1800 mg calcium, 15% of energy from protein)
Number of subjects: 10
Study 15672116 — intervention group
Group type: COMPARATOR
Intervention: Low calcium and normal protein (LC/NP: 500 mg calcium, 15% of energy from protein)
Number of subjects: 10
Study 15672116 — intervention group
Group type: COMPARATOR
Intervention: High calcium and high protein (HC/HP: 1800 mg calcium, 23% of energy from protein)
Number of subjects: 10
Study 12574569 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for 50% to 69% stenosis (n=646)
Number of subjects: 3018
Study 12574569 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for 70% to 99% stenosis without near occlusion (n=429)
Number of subjects: 3018
Study 12574569 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for near occlusion (n=125)
Number of subjects: 3018
Study 12574569 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for <30% stenosis (n=1321)
Number of subjects: 3018
Study 12574569 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for 30% to 49% stenosis (n=478)
Number of subjects: 3018
Study 10564627 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized risk notification and tailored materials
Number of subjects: 901
Study 8708586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive advice + pravastatin
Number of subjects: 681
Study 8708586 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual advice + pravastatin
Number of subjects: 681
Study 8708586 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive advice (no drug)
Number of subjects: 681
Study 8708586 — intervention group
Group type: COMPARATOR
Intervention: Usual advice (no drug)
Number of subjects: 681
Study 1662883 — intervention group
Group type: EXPERIMENTAL
Intervention: Temafloxacin 400 mg
Number of subjects: 279
Study 1662883 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin 400 mg
Number of subjects: 279
Study 6813126 — intervention group
Group type: EXPERIMENTAL
Intervention: NTG-TTS (transdermal therapeutic system for nitroglycerin)
Number of subjects: 13
Study 30185767 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone/WeChat preoperative health education
Number of subjects: 426
Study 30185767 — intervention group
Group type: COMPARATOR
Intervention: Routine preoperative education
Number of subjects: 426
Study 28269510 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation of subthalamic nucleus (STN‐DBS)
Number of subjects: 15
Study 24997007 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based psychological capital intervention (four training sessions over 4 weeks)
Number of subjects: 354
Study 24997007 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 354
Study 22169672 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-stage procedure
Number of subjects: 11
Study 22169672 — intervention group
Group type: COMPARATOR
Intervention: 2-stage procedure
Number of subjects: 11
Study 20225082 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic handgrip exercise at 60% of maximum voluntary contraction for 20 min/day, 5 days/week for 4 weeks
Number of subjects: 11
Study 19110786 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg clopidogrel maintenance dose
Number of subjects: 117
Study 19110786 — intervention group
Group type: COMPARATOR
Intervention: 75 mg clopidogrel maintenance dose (control)
Number of subjects: 117
Study 17130267 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 66
Study 17130267 — intervention group
Group type: COMPARATOR
Intervention: Nonatorvastatin therapy
Number of subjects: 66
Study 12939009 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage implants with screw-retained restorations
Number of subjects: 51
Study 12939009 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage implants with cemented restorations
Number of subjects: 51
Study 12939009 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage implants in completely edentulous patients
Number of subjects: 51
Study 12939009 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-stage implants in partially edentulous patients
Number of subjects: 51